Community Healthcare Trust Incorporated
NYSE:CHCTREIT - Healthcare Facilities
+$0.11 today
- Market cap
- $416.72M
- Beta
- 0.70
- P/E (TTM)
- 78.2
- EPS (TTM)
- $0.22
- Dividend yield
- 10.85%
Volume 0.23M
Average 0.19M
CHCT EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Community Healthcare Trust IncorporatedNYSE: CHCT
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA grows, but more slowly than its trailing trend
Q1 FY2026 EBITDA of $20M rose 5.9% year over year, behind the +22.9% change in trailing-twelve-month EBITDA. Sequentially, it fell 40.8% from the prior quarter. Over 3 fiscal years it compounded at +7.2% a year.
Context
- EBITDA amounted to 68.2% of revenue in FY2025, up 12.8 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 3 analysts of $77.66M (-6.1%) for the fiscal year ending Dec 2026, a slowdown from the +28.8% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $20M-40.8% QoQ
- Last fiscal yearDec 2025
- $82.71M+28.8% YoY
- LTMMar 2026
- $78.53M+22.9% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +5.9% | +362.5% | +356.5 pp |
| 1 year | +28.8% | -6.1% | -34.9 pp |
| 3-year CAGR | +7.2% | -1.1% | -8.3 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 82.71M USD
- Year-over-year change
- +28.8%
- 4-year CAGR
- +6.4%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 82.71M | +28.8% |
| FY2024 | 2024-12-31 | 64.23M | -3.1% |
| FY2023 | 2023-12-31 | 66.25M | -1.3% |
| FY2022 | 2022-12-31 | 67.13M | +4.2% |
| FY2021 | 2021-12-31 | 64.43M | — |
EBITDA vs competitors
How CHCT compares with its peers on the latest reported figures
- CHCT's LTM Mar 2026 EBITDA of $78.53M is the 4th highest of the 10 companies compared; the peer median is $73.51M.
- Its year-over-year change of +22.9% is the 3rd highest of 10, against a peer median of -47.2%.
- EBITDA amounts to 64.2% of revenue for CHCT, versus a peer median of 82.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $251.18M | -64.1% | -17.3% | 268.6% | |
| LTM Mar 2026 | $153.73M | +31.9% | +43.3% | 104.2% | |
| LTM Mar 2026 | $144.91M | -49.5% | — | 131.2% | |
| LTM Mar 2026 | $78.53M | +22.9% | +7.2% | 64.2% | |
| LTM Mar 2026 | $76.05M | +2.0% | -2.2% | 79.2% | |
NHPBPNational Healthcare Properties, Inc. | LTM Mar 2026 | $73.51M | +495.0% | +15.1% | 21.5% |
| LTM Mar 2026 | $64.62M | -6.7% | +5.0% | 43.5% | |
| LTM Mar 2026 | $44.32M | -47.2% | +9.2% | 82.3% | |
| LTM Mar 2026 | $618K | -98.9% | — | 0.6% | |
| LTM Mar 2026 | -$446.03M | -1164.6% | — | 120.1% | |
| Peer median (excluding CHCT) | $73.51M | -47.2% | +7.1% | 82.3% | |
Competitors are the stored peer set for CHCT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 90.58M | 97.68M | 112.85M | 115.79M | 121.2M |
| Cost of Revenue | 15.16M | 16.64M | 20.71M | 22.83M | 110.7M |
| Gross Profit | 75.42M | 81.04M | 92.13M | 92.95M | 10.5M |
| Gross Margin | 83.3% | 83.0% | 81.6% | 80.3% | 8.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 12.11M | 14.84M | 27.34M | 19.06M | 25.1M |
| Operating Expenses | 42.51M | 47.18M | 67.03M | 72.84M | (9.77M) |
| Depreciation & Amortization | 31.23M | 33.19M | 40.44M | 43.71M | 43.54M |
| EBITDA | 64.43M | 67.13M | 66.25M | 64.23M | 82.71M |
| EBITDA Margin | 71.1% | 68.7% | 58.7% | 55.5% | 68.2% |
| Operating Income | 32.91M | 33.87M | 25.1M | 20.12M | 20.27M |
| Operating Margin | 36.3% | 34.7% | 22.2% | 17.4% | 16.7% |
| Interest Income | 57K | 66K | 813K | 530K | (156K) |
| Interest Expense | 10.54M | 11.87M | 17.79M | 23.71M | 34.05M |
| Other Income / Expenses | (10.25M) | (11.81M) | (17.08M) | (23.3M) | (15.14M) |
| Income Before Tax | 22.66M | 22.06M | 8.02M | (3.18M) | 5.13M |
| Pre-Tax Margin | 25.0% | 22.6% | 7.1% | -2.7% | 4.2% |
| Income Tax Expense | 167K | 41K | 306K | 0 | 23K |
| Net Income | 22.49M | 22.02M | 7.71M | (3.18M) | 5.1M |
| Net Margin | 24.8% | 22.5% | 6.8% | -2.7% | 4.2% |
| EPS (Basic) | 0.87 | 0.81 | 0.20 | (0.23) | 0.08 |
| EPS (Diluted) | 0.87 | 0.81 | 0.20 | (0.23) | 0.08 |
| Weighted Avg Shares | 23.26M | 23.63M | 25.2M | 26.53M | 26.86M |
| Weighted Avg Shares (Diluted) | 23.26M | 23.63M | 25.2M | 26.53M | 26.86M |
Community Healthcare Trust Incorporated
NYSE:CHCT
Intrinsic Alpha fair value
Locked
Current Price
$14.50
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.